Statins and noncardiac surgery: Current evidence and practical considerations

Cleveland Clinic Journal of Medicine

Volumn 76, Issue SUPPL. 4, 2009, Pages

  Poldermans, Don ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 6;

ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; HUMAN; INFLAMMATION; OXIDATIVE STRESS; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION;

C-REACTIVE PROTEIN; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INFLAMMATION; INTERLEUKIN-6; OXIDATIVE STRESS; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; RISK ASSESSMENT; RISK FACTORS; RISK REDUCTION BEHAVIOR;

EID: 74349093174     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.76.s4.13     Document Type: Article

References (16)

1. Cohen MC, Aretz TH. Histological analysis of coronary artery lesions in fatal postoperative myocardial infarction. Cardiovasc Pathol 1999; 8:133-139.
2. Dawood MM, Gutpa DK, Southern J, et al. Pathology of fatal perioperative myocardial infarction: implications regarding pathophysiology and prevention. Int J Cardiol 1996; 57:37-44.
3. Ridker PM, Cannon CP, Morrow D, et al. C-reactive protein levels and outcomes after statin therapy. N Engl J Med 2005; 352:20-28.
4. Poldermans D, Bax J, Boersma E, et al. Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. European Society of Cardiology Web site. http://www.escardio.org/guidelines-surveys/esc-guidelines/GuidelinesDocu ments/guidelines-perioperative-cardiac-care-FT.pdf. Posted September 1, 2009. Accessed September 3, 2009.
5. Durazzo AE, Machado FS, Ikeoka DT, et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. J Vasc Surg 2004; 39:967-976.
6. Lindenauer PK, Pekow P, Wang K, Gutierrez B, Benjamin EM. Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery. JAMA 2004; 291:2092-2099.
7. Kertai MD, Boersma E, Westerhout CM, et al. A combination of statins and beta-blockers is independently associated with a reduction in the incidence of perioperative mortality and nonfatal myocardial infarction in patients undergoing abdominal aortic aneurysm surgery. Eur J Vasc Endovasc Surg 2004; 28:343-352.
8. O'Neil-Callahan K, Katsimaglis G, Tepper MR, et al. Statins decrease perioperative cardiac complications in patients undergoing noncardiac vascular surgery: the Statins for Risk Reduction in Surgery (StaRRS). J Am Coll Cardiol 2005; 45:336-342.
9. Poldermans D, Bax JJ, Kertai MD, et al. Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation 2003; 107:1848-1851.
10. Schouten O, Boersma E, Hoeks SE, et al, for the Dutch Echocar-diographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. Fluvastatin and perioperative events in patients undergoing vascular surgery. N Engl J Med 2009; 361:980-989.
11. Heeschen C, Hamm CW, Laufs U, Snapinn S, Bohm M, White HD. Withdrawal of statins increases event rates in patients with acute coronary syndromes. Circulation 2002; 105:1446-1452.
12. Schouten O, Hoeks SE, Welten GM, et al. Effect of statin withdrawal on frequency of cardiac events after vascular surgery. Am J Cardiol 2007; 100:316-320.
13. Gupta R, Plantinga LC, Fink NE, et al. Statin use and hospitalization for sepsis in patients with chronic kidney disease. JAMA 2007; 297:1455-1464.
14. Yasuda H, Yuen PS, Hu X, et al. Simvastatin improves sepsisinduced mortality and acute kidney injury via renal vascular effects. Kidney Int 2006; 69:1535-1542.
15. Sabbatini M, Pisani A, Uccello F, et al. Atorvastatin improves the course of ischemic acute renal failure in aging rats. J Am Soc Nephrol 2004; 15:901-909.
16. Welten GMJM, Chonchol M, Schouten O, et al. Statin use is associated with early recovery of kidney injury after vascular surgery and improved long-term outcome. Nephrol Dial Transplant 2008; 23:3867-3873.